Canadian Medical Center Co. announces its Annual Financial Results for the Period Ending on 2022-12-31
|Element List||Current Year||Previous Year||%Change|
|Gross Profit (Loss)||24,972,240||25,192,878||-0.88|
|Operational Profit (Loss)||17,257,421||16,300,962||5.87|
|Net Profit (Loss) after Zakat and Tax||15,654,263||14,063,361||11.31|
|Total Comprehensive Income||15,659,852||13,782,442||13.62|
|Total Share Holders Equity (after Deducting Minority Equity)||87,009,913||94,450,061||-7.88|
|Profit (Loss) per Share||2.03||1.83|
|All figures are in (Actual) Saudi Arabia, Riyals|
|The reason of the increase (decrease) in the net profit during the current year compared to the last year is||Canadian General Medical Center Co. achieved a net profit after zakat of SAR 15.65 million during 2022, by an increase of 11.312% on an annual basis compared to SAR 14.06 million in the year 2021. The reason for this increase is mainly due to: |
1- The company operating revenues increased in the year 2022 compared to the year 2021.
2- A decrease in the costs in the year 2022 compared to the year 2021.
Operating revenues increased by 14.986% on an annual basis, to reach SAR 81.23 million in 2022, compared to SAR 70.64 million in 2021, mainly due to the increase in year 2022 revenues, compared to revenues in 2021.
|Statement of the type of external auditor's report||Unmodified opinion|
|Modification, Qualification or Emphasis of a Matter as Stated within the External Auditor Opinion||The company financial statements for the year ended on 31 December 2021 were audited by another auditor who expressed an unmodified opinion on those statements on 24 March 2022.|
|Reclassification of Comparison Items||None|
|Additional Information||The earnings per share for the year 2022 increased to SAR 2.03 per share, compared to SAR 1.83 per share for the year 2021, mainly due to increase in net profits.|
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.